AI stock news summaries
The news on your stocks, in plain English.
Each headline and SEC filing gets a short summary and a 1–10 score, linked to its source.
Skim a day of news in minutes
- Every headline, readNews and filings on your watchlist, read through the day.
- Off-topic, filteredA separate check drops stories that only mention the company.
- Short, with a linkUp to three sentences, with the source one click away.
One real example
One summary
AbbVie’s acquisition of Apogee, as Vero summarized and scored it.
ABBV · Sep 3, 20269/10
AbbVie completes acquisition of Apogee Therapeutics for $10.9B
AbbVie completed its acquisition of Apogee Therapeutics for about $10.9 billion, paying $135.11 per share in cash. The deal deepens AbbVie's immunology pipeline with Apogee assets like zumilokibart (APG777) and APG273.
If you own ABBV: AbbVie adds Apogee’s immunology assets to its pipeline, aiming to strengthen leadership and long-term growth.
Read the filing on SEC EDGAR